Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lale Kostakoglu

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Oncology Reports|October 25, 2011
Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiationEric C Ko, Eric M Genden, Krzysztof Misiukiewicz, et al.
The Journal of Urology|November 12, 2003
Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigenDavid M Nanus, Matthew I Milowsky, Lale Kostakoglu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2017
Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using <sup>18</sup>F-Fluciclovine PET/CTMatthew P Miller, Lale Kostakoglu, Daniel Pryma, et al.
Clinical Imaging|August 11, 2018
Updating the role of FDG PET/CT for evaluation of lung cancer manifesting in nonsolid nodulesYing Liu, David F Yankelevitz, Lale Kostakoglu, et al.
Cancer|June 23, 2009
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancerJohnny Kao, Ha Linh Vu, Eric M Genden, et al.
Leukemia & Lymphoma|October 1, 2015
Lymph nodes can accurately be measured on PET-CT for lymphoma staging/restaging without a concomitant contrast enhanced CT scanWilliam L Simpson, Karen M Lee, Ninoska Sosa, et al.
The Journal of Urology|September 5, 2018
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE TrialGerald L Andriole, Lale Kostakoglu, Albert Chau, et al.
Nuclear Medicine Communications|July 11, 2013
Dual-isotope SPECT/CT impact on hospitalized patients with suspected diabetic foot infection: saving limbs, lives, and resourcesSherif Heiba, Dov Kolker, Leonard Ong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy studies using 90Y- and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigenShankar Vallabhajosula, Stanley J Goldsmith, Klaus A Hamacher, et al.
Abdominal Radiology (New York)|June 28, 2018
Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot studyMelissa Schwartz, Somali C Gavane, Jad Bou-Ayache, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Oncology Reports|October 25, 2011
Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiationEric C Ko, Eric M Genden, Krzysztof Misiukiewicz, et al.
The Journal of Urology|November 12, 2003
Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigenDavid M Nanus, Matthew I Milowsky, Lale Kostakoglu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2017
Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using <sup>18</sup>F-Fluciclovine PET/CTMatthew P Miller, Lale Kostakoglu, Daniel Pryma, et al.
Clinical Imaging|August 11, 2018
Updating the role of FDG PET/CT for evaluation of lung cancer manifesting in nonsolid nodulesYing Liu, David F Yankelevitz, Lale Kostakoglu, et al.
Cancer|June 23, 2009
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancerJohnny Kao, Ha Linh Vu, Eric M Genden, et al.
Leukemia & Lymphoma|October 1, 2015
Lymph nodes can accurately be measured on PET-CT for lymphoma staging/restaging without a concomitant contrast enhanced CT scanWilliam L Simpson, Karen M Lee, Ninoska Sosa, et al.
The Journal of Urology|September 5, 2018
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE TrialGerald L Andriole, Lale Kostakoglu, Albert Chau, et al.
Nuclear Medicine Communications|July 11, 2013
Dual-isotope SPECT/CT impact on hospitalized patients with suspected diabetic foot infection: saving limbs, lives, and resourcesSherif Heiba, Dov Kolker, Leonard Ong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy studies using 90Y- and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigenShankar Vallabhajosula, Stanley J Goldsmith, Klaus A Hamacher, et al.
Abdominal Radiology (New York)|June 28, 2018
Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot studyMelissa Schwartz, Somali C Gavane, Jad Bou-Ayache, et al.
Pageof 12